Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: This is what a buyout does

although this is a drug company look at what happened when Alegra bout Tobira $4->$40

Hopefully POET execs get the news out re prototypes and NRE and good financial updates soon.

http://www.wsj.com/articles/allergan-agrees-to-buy-tobira-therapeutics-in-1-7-billion-deal-1474376639

Share
New Message
Please login to post a reply